Autonomix Medical (AMIX) Cash & Equivalents (2022 - 2025)

Autonomix Medical (AMIX) has 4 years of Cash & Equivalents data on file, last reported at $9.9 million in Q4 2025.

• On a quarterly basis, Cash & Equivalents fell 16.1% year-over-year to $9.9 million in Q4 2025; TTM through Dec 2025 was $9.9 million, a 16.1% decrease from a year earlier, with the FY2025 full-year figure at $9.1 million, up 6.13% from the prior year.
• Cash & Equivalents for Q4 2025 stood at $9.9 million, up from $7.5 million in the prior quarter.
• Over the last five years, Cash & Equivalents for AMIX reached as high as $11.8 million in Q4 2024 and fell as low as $810000.0 in Q4 2022.
• Historically, Cash & Equivalents has averaged $6.4 million across 4 years, with a median of $7.5 million in 2025.
• Across the five-year window, Cash & Equivalents soared 895.14% in 2024 and fell 16.1% in 2025, its largest moves.
• Year by year, Cash & Equivalents stood at $810000.0 in 2022, then soared by 50.37% to $1.2 million in 2023, then soared by 868.8% to $11.8 million in 2024, then retreated by 16.1% to $9.9 million in 2025.
• Per Business Quant data, the three most recent Cash & Equivalents figures were $9.9 million in Q4 2025, $7.5 million in Q3 2025, and $8.6 million in Q2 2025.